Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Key Market Drivers
Growth in Pharmaceutical Industry
The continued expansion of the pharmaceutical sector is a major growth driver for the Vitamin B12 market. With global pharmaceutical revenues reaching USD 1.6 trillion by 2023, the industry has become a key consumer of Vitamin B12, particularly in applications related to anemia, neurological health, and prenatal care. Vitamin B12 is indispensable for red blood cell formation, nervous system function, and DNA replication, making it a staple ingredient in a variety of pharmaceutical products. Increased awareness about deficiencies - especially among vegetarians, the elderly, and individuals with absorption issues - has further accelerated demand. Companies like EUROAPI, which remains the only Western-based producer of Vitamin B12 for pharmaceutical use, continue to innovate with advanced fermentation technologies to meet global supply needs.Key Market Challenges
High Production Costs
High production costs present a major challenge in the Vitamin B12 market. Manufacturing bioactive forms like methylcobalamin involves complex microbial fermentation processes and sophisticated purification methods. These procedures require stringent environmental controls and high operational precision, significantly driving up costs. Production yields can vary due to inconsistencies in microbial performance and raw material quality, leading to inefficiencies and wastage. Furthermore, maintaining product purity and stability demands advanced technology and rigorous quality control, particularly in regions with elevated labor and energy costs. These factors make large-scale production costly and reduce profitability for manufacturers, especially smaller enterprises.Key Market Trends
Expansion of Nutraceutical Applications
The growing popularity of nutraceuticals is a key trend bolstering the Vitamin B12 market. Increasing consumer focus on preventive healthcare and overall wellness is driving demand for Vitamin B12 in functional foods and dietary supplements. In India, for instance, the government introduced fortified nutritional products like Jan Aushadhi Poshan under the PMBJP initiative, containing Vitamin B12 among other vital nutrients. B12’s recognized benefits in energy production, cognitive health, and immune support are making it a popular addition to multivitamins, fortified drinks, and meal replacement formulas. With health-conscious lifestyles becoming more prevalent, especially in North America, Europe, and Asia-Pacific, manufacturers are actively expanding their nutraceutical product lines enriched with B12.Key Market Players
- Hebei Yuxing Bio-Engineering Co., Ltd.
- Hebei Huarong Pharmaceutical Co., Ltd
- North China Pharmaceutical Group Corp. (NCPC)
- Ningxia Kingvit Pharmaceutical CO., LTD
- Euroapi
- DSM
Report Scope
In this report, the Global Vitamin B12 Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:Vitamin B12 Market, By Sales Channel:
- Direct
- Indirect
Vitamin B12 Market, By End Use:
- Pharmaceutical
- Animal Feed
- Food & Beverages
- Healthcare
- Personal Care
- Others
Vitamin B12 Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Vitamin B12 Market.Available Customizations
With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.Company Information
- Detailed analysis and profiling of additional market players (up to five).
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Hebei Yuxing Bio-Engineering Co., Ltd.
- Hebei Huarong Pharmaceutical Co., Ltd
- North China Pharmaceutical Group Corp. (NCPC)
- Ningxia Kingvit Pharmaceutical CO.,LTD
- Euroapi
- DSM
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 185 |
| Published | May 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 165.09 Million |
| Forecasted Market Value ( USD | $ 199.02 Million |
| Compound Annual Growth Rate | 2.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 6 |


